ADRENAL CORTICAL CARCINOMA
Clinical trials for ADRENAL CORTICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADRENAL CORTICAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADRENAL CORTICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver metastases: immune booster combined with targeted chemo
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard chemotherapy delivered directly to the liver can help people with colorectal, bile duct, or adrenal cancer that has spread to the liver. About 70 adults will receive the drug combination along with a s…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Custom mRNA vaccine takes on rare endocrine cancers
Disease control Recruiting nowThis early study tests a personalized mRNA vaccine (mRNA-0523-L001) for people with advanced endocrine tumors like adrenal cancer, medullary thyroid cancer, and pancreatic neuroendocrine tumors who have no standard treatment left. The vaccine is made to target unique mutations in…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug cocktail aims to shrink Hard-to-Treat adrenal tumors
Disease control Recruiting nowThis phase II trial is testing whether combining cabozantinib (a drug that blocks tumor growth and blood vessel formation) with pembrolizumab (an immunotherapy that helps the immune system attack cancer) can shrink tumors in people with advanced adrenocortical carcinoma. The stud…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Immunotherapy drug aims to keep adrenocortical cancer at bay
Disease control Recruiting nowThis phase 2 trial is testing whether the immunotherapy drug cemiplimab can delay or prevent cancer progression in people with advanced adrenocortical cancer whose disease has been stabilized by initial chemotherapy. About 31 participants will receive cemiplimab every three weeks…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Rare cancer study aims to unlock secrets of adrenal tumors
Knowledge-focused Recruiting nowThis study looks back at the medical records of 60 adults treated for adrenal cortex carcinoma at a French hospital. Researchers want to learn more about the disease's features and how long patients live after treatment. The goal is to better understand this rare cancer and impro…
Matched conditions: ADRENAL CORTICAL CARCINOMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC